Bortezomib Impurity 105
- CAS1310383-72-2
- CatalogueRS-B045011
- FormulaC15H28BNO2.C2Hf3O2
- MW265.21
CUSTOM SYNTHESIS
On this page
Product identification
| Product name | Bortezomib Impurity 105 |
|---|---|
| Catalogue No. | RS-B045011 |
| CAS No. | 1310383-72-2 |
| Molecular formula | C15H28BNO2.C2Hf3O2 |
| Molecular weight | 265.21 |
| Availability | Custom synthesis— made to order, typically 3–4 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Bortezomib |
| Also known as | rel-(R)-3-Methyl-1-((3aS,4R,6R,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butan-1-amine 2,2,2-trifluoroacetate; Bortezomib Impurity 3 |
| Storage | 2–8 °C (refrigerated), protect from light |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-B045011 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
A certificate of analysis (COA) is issued for the lot you receive. It records the catalogue number
RS-B045011 and the batch number, the tests performed, the
specification applied and the result obtained. A safety data sheet is supplied with the shipment.
Is the assigned value given on an “as is” basis?
Content and purity are stated per lot on the certificate of analysis, on an “as is” basis unless the certificate says otherwise. The analytical basis for the assigned value is stated on the certificate.
How should this material be stored?
Store as stated: 2–8 °C (refrigerated), protect from light. Re-test before use beyond the retest date printed on the certificate.
Do you supply pack sizes other than those listed?
Pack sizes are confirmed with the quotation. Quantities beyond the standard pack sizes can be quoted — send the quantity you need with your enquiry.
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Bortezomib
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-B045011
- Request a quotation for RS-B045011
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Bortezomib
All 72 further standards are listed here — every link is in the page, not loaded later.
-
Bortezomib
IN STOCKRS-I012041 -
Bortezomib Impurity F
IN STOCKRS-B045045 -
Bortezomib Impurity G
IN STOCKRS-B045004 -
Bortezomib Impurity H
IN STOCKRS-B045013 -
Bortezomib Impurity H (1132709-15-9)
IN STOCKRS-B045005 -
Bortezomib Impurity I
IN STOCKRS-B045022 -
Bortezomib Impurity J
IN STOCKRS-B045024 -
Bortezomib Impurity L
IN STOCKRS-B045036 -
Bortezomib Impurity M
IN STOCKRS-B045037 -
Bortezomib Impurity O
BACK ORDERRS-B045010 -
Bortezomib Impurity Z
IN STOCKRS-B045001 -
(1R,2S)-Bortezomib-d5
IN STOCKRS-B045040 -
2,4,4,5,5-Pentamethyl-1,3,2-dioxaborolane
IN STOCKRS-B045061 -
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine
IN STOCKRS-Z401DDV -
Bortezomib (1S,2R)-Isomer
IN STOCKRS-B045006 -
Bortezomib Amide Impurity
IN STOCKRS-B045023 -
Bortezomib Isoamyl Impurity
CUSTOM SYNTHESISRS-B045012 -
Isobutyl Chloride
IN STOCKRS-B045025 -
Bortezomib Impurity 1
IN STOCKRS-B045056 -
Bortezomib Impurity 10
IN STOCKRS-I001AK5 -
Bortezomib Impurity 19(Hydrochloride)
IN STOCKRS-B045047 -
Bortezomib Impurity 25 Monomer
CUSTOM SYNTHESISRS-B045051 -
Bortezomib Impurity 27 Sodium Salt
IN STOCKRS-Z401CTT -
Bortezomib Impurity 29 Hydrochloride
IN STOCKRS-B045041 -
Bortezomib Impurity 38
IN STOCKRS-I001AWN -
Bortezomib Impurity 51 (18680-27-8)
IN STOCKRS-B045063 -
Bortezomib Impurity 52
CUSTOM SYNTHESISRS-B045073 -
Bortezomib Impurity 52
IN STOCKRS-I001854 -
Bortezomib Impurity 54
CUSTOM SYNTHESISRS-B045027 -
Bortezomib Impurity 54 HCl
BACK ORDERRS-B045017 -
Bortezomib Impurity 56
IN STOCKRS-B045002 -
Bortezomib Impurity 61
IN STOCKRS-I001718 -
Bortezomib Impurity 66
IN STOCKRS-Z401I5A -
Bortezomib Impurity 84
BACK ORDERRS-Z401G1K -
Bortezomib Impurity 87
IN STOCKRS-B045069 -
Bortezomib Impurity 92
BACK ORDERRS-B045050 -
Bortezomib Impurity 106
IN STOCKRS-B045014 -
Bortezomib Impurity 107
IN STOCKRS-B045018 -
Bortezomib Impurity 108
IN STOCKRS-B045019 -
Bortezomib Impurity 109
IN STOCKRS-B045029 -
Bortezomib Impurity 110
IN STOCKRS-B045039 -
Bortezomib Impurity 111
IN STOCKRS-B045049 -
Bortezomib Impurity 112
IN STOCKRS-B045053 -
Bortezomib Impurity 113
CUSTOM SYNTHESISRS-B045062 -
Bortezomib Impurity 114
CUSTOM SYNTHESISRS-B045065 -
Bortezomib Impurity 129
IN STOCKRS-B045007 -
Bortezomib Impurity 131
CUSTOM SYNTHESISRS-B045009 -
Bortezomib Impurity 133
IN STOCKRS-B045020 -
Bortezomib Impurity 134
IN STOCKRS-B045021 -
Bortezomib Impurity 135
BACK ORDERRS-B045026 -
Bortezomib Impurity 136
IN STOCKRS-B045031 -
Bortezomib Impurity 137
CUSTOM SYNTHESISRS-B045032 -
Bortezomib Impurity 138
IN STOCKRS-B045033 -
Bortezomib Impurity 139
IN STOCKRS-B045034 -
Bortezomib Impurity 140
IN STOCKRS-B045035 -
Bortezomib Impurity 141
CUSTOM SYNTHESISRS-B045038 -
Bortezomib Impurity 142
IN STOCKRS-B045042 -
Bortezomib Impurity 143
IN STOCKRS-B045043 -
Bortezomib Impurity 144
IN STOCKRS-B045044 -
Bortezomib Impurity 145
IN STOCKRS-B045046 -
Bortezomib Impurity 146
IN STOCKRS-B045048 -
Bortezomib Impurity 147
IN STOCKRS-B045054 -
Bortezomib Impurity 149
IN STOCKRS-B045057 -
Bortezomib Impurity 150
IN STOCKRS-B045059 -
Bortezomib Impurity 151
IN STOCKRS-B045060 -
Bortezomib Impurity 152
IN STOCKRS-B045064 -
Bortezomib Impurity 153
IN STOCKRS-B045066 -
Bortezomib Impurity 155
IN STOCKRS-B045068 -
Bortezomib Impurity 156
CUSTOM SYNTHESISRS-B045070 -
Bortezomib Impurity 157
IN STOCKRS-B045071 -
Bortezomib Impurity 158
IN STOCKRS-B045072 -
Bortezomib Impurity 222
BACK ORDERRS-B045074
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.